An Update on Clostridioides difficile Binary Toxin.

Area of Science:

• Microbiology
• Infectious Diseases
• Gastroenterology

Background:

• Clostridioides difficile infection (CDI) is a significant healthcare-associated pathogen.
• Toxin A (TcdA) and Toxin B (TcdB) are key virulence factors in CDI.
• The role of Clostridioides difficile binary toxin (CDT) in CDI pathogenesis is not fully understood.

Purpose of the Study:

• To describe the main features of CDT.
• To evaluate the impact of CDT on the host during CDI.
• To discuss the clinical relevance, epidemiology, and potential therapeutics for CDT-producing C. difficile.

Main Methods:

• Literature review of studies on Clostridioides difficile binary toxin.
• Analysis of existing data on CDT's biochemical properties and mechanisms of action.
• Synthesis of clinical and epidemiological findings related to CDT-producing strains.

Main Results:

• CDT is a tripartite toxin with ADP-ribosyltransferase activity.
• CDT is thought to enhance TcdA and TcdB toxicity, potentially increasing disease severity.
• Prevalence of CDT-producing strains varies geographically and temporally.

Conclusions:

• CDT's precise role in CDI pathogenesis requires further elucidation.
• Understanding CDT's impact is crucial for developing targeted therapies.
• Further research into CDT epidemiology and therapeutic strategies is warranted.